Back

Nationwide trends in utilization and safety of ventricular arrythmia ablation in patients with hypertrophic cardiomyopathy

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Novel insights into Brugada syndrome and hypertrophic cardiomyopathy Ablation of Ventricular Arrhythmias ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Guy Rozen

Tufts Medical Center, Inc., Boston (United States of America)

7 More presentations in this session

Presentation thumbnail
Relationship between epicardial adipose tissue and ventricular fibrillation in Brugada syndrome by cardiac computed tomography analysis
Mr K. Yonezu (Yufu City, JP)
Abstract Slides Video
Presentation thumbnail
Prognostic parameters predict cardiac events in Brugada syndrome: a meta-analysis
Mr P. Pajareya (Bangkok, TH)
Abstract Slides Video
Presentation thumbnail
Refining risk stratification in hypertrophic cardiomyopathy: the role of late gadolinium enhancement and syncope in predicting adverse outcomes
Doctor C. Mann (Vienna, AT)
Abstract Slides Video
Presentation thumbnail
Novel electric predictors of lethal arrhythmic event in patients with hypertrophic cardiomyopathy
Professor J. Choi (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Prevalence of cardiovascular comorbidities among hospitalized patients with hypertrophic cardiomyopathy and factors associated with a higher case-fatality rate
Doctor S. Shoar (Largo, US)
Abstract Slides Video

Access the full session

Session thumbnail
Novel insights into Brugada syndrome and hypertrophic cardiomyopathy

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Effect of catheter ablation vs medical therapy on cardiovascular outcomes in hypertrophic cardiomyopathy with atrial fibrillation
thumbnail
Congress Presentation
Long-term efficacy and safety of ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy
thumbnail
Congress Presentation
Genotype, phenotype and outcomes of patients with hypertrophic cardiomyopathy referred for ablation of ventricular tachycardia

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources